Obesities,
Journal Year:
2024,
Volume and Issue:
4(3), P. 226 - 255
Published: July 22, 2024
Obesity
has
emerged
as
a
major
public
health
challenge
in
the
21st
century,
contributing
to
rising
prevalence
of
metabolic
syndrome
(MetS),
cluster
interrelated
risk
factors.
These
factors
include
obesity
or
abdominal
obesity,
type
2
diabetes
mellitus
(T2DM),
hypertension
(HTN),
and
dyslipidaemia.
In
this
review,
we
will
explore
important
aspects
regulation
dynamics
lipoprotein
metabolism
see
how
they
underlie
each
these
risks.
Additionally,
highlight
role
ferroptosis,
an
iron-dependent
regulated
cell
death
process,
relation
inflammatory
responses
its
critical
contribution
pathophysiology
MetS.
inflammasome
activation,
lipotoxicity,
influence
adipocytokines,
adipose
tissue
macrophages.
By
exploring
interconnections,
review
aims
provide
insights
into
crosstalk,
outline
pathological
mechanisms
occurring,
identify
potential
therapeutic
targets
for
managing
preventing
progression
Pharmacological Research,
Journal Year:
2024,
Volume and Issue:
203, P. 107155 - 107155
Published: March 23, 2024
Non-alcoholic
fatty
liver
disease
(NAFLD)
encompasses
hepatic
steatosis,
non-alcoholic
steatohepatitis
(NASH),
fibrosis,
cirrhosis,
and
hepatocellular
carcinoma.
It
is
the
primary
cause
of
chronic
disorders,
with
a
high
prevalence
but
no
approved
treatment.
Therefore,
it
indispensable
to
find
trustworthy
therapy
for
NAFLD.
Recently,
mounting
evidence
illustrates
that
Sirtuin
1
(SIRT1)
strongly
associated
SIRT1
activation
or
overexpression
attenuate
NAFLD,
while
deficiency
aggravates
Besides,
an
array
therapeutic
agents,
including
natural
compounds,
synthetic
traditional
Chinese
medicine
formula,
stem
cell
transplantation,
alleviates
NALFD
via
upregulation.
Mechanically,
NAFLD
by
reestablishing
autophagy,
enhancing
mitochondrial
function,
suppressing
oxidative
stress,
coordinating
lipid
metabolism,
as
well
reducing
hepatocyte
apoptosis
inflammation.
In
this
review,
we
introduced
structure
function
briefly,
summarized
effect
on
its
mechanism,
along
application
agonists
in
treating
Frontiers in Cell and Developmental Biology,
Journal Year:
2025,
Volume and Issue:
13
Published: Feb. 20, 2025
Liver
disease
is
a
significant
global
health
issue,
responsible
for
millions
of
deaths
annually.
Aging,
characterized
by
the
gradual
decline
in
cellular
and
physiological
functions,
impairs
tissue
regeneration,
increases
susceptibility
to
liver
diseases,
leads
health.
Silent
information
regulator
1
(SIRT1),
NAD⁺-dependent
deacetylase,
has
emerged
as
pivotal
factor
modulating
age-related
changes
liver.
SIRT1
preserves
function
regulating
essential
aging-related
pathways,
including
telomere
maintenance,
epigenetic
modifications,
senescence,
intercellular
communication,
inflammation,
mitochondrial
function.
Notably,
levels
naturally
with
age,
contributing
progression
increased
vulnerability
injury.
This
review
summarizes
regulatory
role
aging
its
impact
on
diseases
such
fibrosis,
alcoholic
associated
(ALD),
metabolic
dysfunction-associated
steatotic
(MASLD),
steatohepatitis
(MASH),
hepatocellular
carcinoma
(HCC).
We
also
discuss
emerging
therapeutic
approaches,
activators,
gene
therapy,
nutritional
interventions,
which
are
evaluated
their
potential
restore
mitigate
progression.
Finally,
we
highlight
future
research
directions
optimize
SIRT1-targeted
therapies
clinical
applications
conditions.
Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(8), P. 970 - 970
Published: Aug. 8, 2024
Osteoporosis
(OP)
is
a
common
metabolic
bone
disease
characterized
by
low
mass,
decreased
mineral
density,
and
degradation
of
tissue
microarchitecture.
However,
our
understanding
the
mechanisms
remodeling
factors
affecting
mass
remains
incomplete.
Sirtuin1
(SIRT1)
nicotinamide
adenine
dinucleotide-dependent
deacetylase
that
regulates
variety
cellular
metabolisms,
including
inflammation,
tumorigenesis,
metabolism.
Recent
studies
have
emphasized
important
role
SIRT1
in
homeostasis.
This
article
reviews
metabolism
OP
also
discusses
therapeutic
strategies
future
research
directions
for
targeting
SIRT1.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Jan. 29, 2025
Succinylation
represents
an
emerging
class
of
post-translational
modifications
(PTMs),
characterized
by
the
enzymatic
or
non-enzymatic
transfer
a
negatively
charged
four-carbon
succinyl
group
to
ϵ-amino
lysine
residues,
mediated
succinyl-coenzyme
A.
Recent
studies
have
highlighted
involvement
succinylation
in
various
diseases,
particularly
cancer
progression.
Sirtuin
5
(SIRT5),
member
sirtuin
family,
has
been
extensively
studied
for
its
robust
desuccinylase
activity,
alongside
deacetylase
function.
To
date,
only
limited
number
SIRT5
substrates
identified.
These
mediate
diverse
physiological
processes
such
as
glucose
oxidation,
fatty
acid
ammonia
detoxification,
reactive
oxygen
species
scavenging,
anti-apoptosis,
and
inflammatory
responses.
The
regulation
these
activities
can
occur
through
either
same
activity
acting
on
different
distinct
targeting
substrate.
Aberrant
expression
closely
linked
tumorigenesis
disease
progression;
however,
role
remains
controversial.
exhibits
dual
functionalities:
it
promote
tumor
proliferation,
metastasis,
drug
resistance,
metabolic
reprogramming,
thereby
oncogene;
conversely,
also
inhibit
cell
growth
induce
apoptosis,
functioning
suppressor
gene.
This
review
aims
provide
comprehensive
overview
current
research
status
SIRT5.
We
discuss
structural
characteristics
regulatory
mechanisms,
compare
functions
with
other
family
members,
elucidate
mechanisms
regulating
activity.
Specifically,
we
focus
modification
progression,
highlighting
how
desuccinylation
modulates
development
delineating
underlying
involved.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 30, 2025
Abstract
Liver
disease
poses
a
significant
threat
to
global
public
health,
with
arsenic
(As)
recognized
as
major
environmental
toxin
contributing
liver
injury.
However,
the
specific
mechanisms
and
protective
effects
of
α‐lipoic
acid
(LA)
remain
unclear.
Therefore,
this
study
employs
network
toxicology
pharmacology
comprehensively
analyze
hepatotoxic
mechanism
As
hepatoprotective
LA,
further
verifies
peroxisomal
β‐oxidation
lipophagy
in
process.
The
analysis
results
show
that
induces
damage
mainly
through
autophagy,
apoptosis,
lipid
metabolism,
oxidative
stress,
whereas
LA
exerts
its
properties
by
regulating
metabolism.
Further
verifications
find
inhibits
SIRT1
expression,
activates
P53
Notch
pathways,
damages
mitochondria,
β‐oxidation,
increases
accumulation,
enhances
liver,
while
intervention
alleviates
As‐induced
accumulation
targeting
SIRT1,
ameliorating
mitochondrial
damage,
enhancing
thereby
alleviating
damage.
This
clarifies
hepatotoxicity
provides
theoretical
basis
for
potential
agent.
Experimental Gerontology,
Journal Year:
2025,
Volume and Issue:
201, P. 112702 - 112702
Published: Feb. 6, 2025
Brown
adipose
tissue
(BAT)
is
the
primary
site
for
non-shivering
thermogenesis
in
body
and
plays
a
crucial
role
maintaining
core
temperature.
However,
its
function
gradually
declines
with
age.
To
mitigate
age-related
decline
BAT
thermogenic
capacity,
we
treated
progeroid
mice
metformin
to
investigate
potential
mechanisms
by
which
can
slow
reduction
function.
We
found
that
mice,
after
receiving
treatment,
showed
significant
improvement
senescent
state
of
brown
adipocytes
through
activation
SIRT1,
effectively
reduced
mitochondrial
oxidative
stress.
Additionally,
slowed
UCP1
expression
levels
tissue,
thereby
capacity
mice.
Moreover,
inflammatory
responses
around
cells,
further
improving
overall
tissue.
These
findings
suggest
down
aging
process
targeting
enhancing
capacity.
ABSTRACT
Background
Spinal
cord
injury
(SCI)
is
a
complex
central
nervous
system
disorder
characterized
by
multifaceted
pathological
processes,
including
inflammation,
oxidative
stress,
programmed
cell
death,
autophagy,
and
mitochondrial
dysfunction.
Sirtuin
1
(Sirt1),
critical
NAD
+
‐dependent
deacetylase,
has
emerged
as
promising
therapeutic
target
for
SCI
repair
due
to
its
potential
protect
neurons,
regulate
glial
vascular
cells,
optimize
the
microenvironment.
However,
regulatory
roles
of
Sirt1
in
are
challenging,
effects
vary
depending
on
activation
timing,
expression
levels,
types.
Methods
A
systematic
literature
review
was
conducted
using
PubMed,
Scopus,
Web
Science
identify
studies
investigating
SCI.
Relevant
publications
were
analyzed
synthesize
current
evidence
Sirt1's
mechanisms,
effects,
challenges
repair.
Results
exerts
broad
across
diverse
processes
types
post‐SCI.
It
promotes
neuronal
survival
axonal
regeneration,
modulates
astrocytes
microglia
resolve
supports
oligodendrocyte‐mediated
myelination,
enhances
endothelial
function.
Proper
may
mitigate
secondary
injury,
whereas
excessive
or
prolonged
could
impair
inflammatory
resolution
disrupt
cellular
homeostasis.
This
highlights
therapies,
but
include
optimizing
spatiotemporal
addressing
dual
different
Conclusion
Targeting
represents
viable
strategy
repair,
given
regulation
neuroprotection,
immunomodulation,
tissue
remodeling.
translating
these
findings
into
therapies
requires
resolving
issues
such
type‐specific
delivery,
precise
dosage
control.
provides
theoretical
foundation
practical
insights
advancing
Sirt1‐based
treatments